Table 2.
Incidence of P. aeruginosa and S. aureus at three assessment points and overall incidence in the EGF-CMC and CMC groups.
| Evaluation | EGF-CMC Group (n = 14) | CMC Group (n = 11) | Fisher’s Exact Test p-Value Comparing the Incidences in Both Groups | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| P. aeruginosa | S. aureus | P. aeruginosa | S. aureus | |||||||
| Number of Cases | Incidence | Number of Cases | Incidence | Number of Cases | Incidence | Number of Cases | Incidence | P. aeruginosa | S. aureus | |
| Week 1 | 3 | 21.4% | 3 | 21.4% | 2 | 18.2% | 2 | 18.2% | 1.000 | 1.000 |
| Week 6 | 3 | 21.4% | 1 | 7.1% | 1 | 9.1% | 3 | 27.3% | 0.604 | 0.288 |
| Week 12 | 5 | 35.7% | 1 | 7.1% | 1 | 9.1% | 3 | 27.3% | 0.180 | 0.288 |
| Just one evaluation * | 8 | 57.1% | 4 | 28.6% | 3 | 27.3% | 6 | 54.5% | 0.227 | 0.241 |
* Patients who presented isolation in at least one of the three evaluations.